Search
Flezurafenib
go.drugbank.com/drugs/DB21725ExperimentalFlezurafenib is a small molecule drug. The usage of the INN stem '-rafenib' in the name indicates that Flezurafenib is a Raf (rapidly accelerated fibrosarcoma) kinase inhibitor.
Lanepitant
go.drugbank.com/drugs/DB19599ExperimentalLanepitant is a small molecule drug. The usage of the INN stem '-pitant' in the name indicates that Lanepitant is a neurokinin NK1 (substance P) receptor antagonist.
Dexsecoverine
go.drugbank.com/drugs/DB19837ExperimentalDexsecoverine is a small molecule drug. The usage of the INN stem '-verine' in the name indicates that Dexsecoverine is a spasmolytic with a papaverine-like action.
Tuvatidine
go.drugbank.com/drugs/DB21229ExperimentalTuvatidine is a small molecule drug. The usage of the INN stem '-tidine' in the name indicates that Tuvatidine is a histamine- H2-receptor antagonist, cimetidine derivative.
Uplarafenib
go.drugbank.com/drugs/DB21661ExperimentalUplarafenib is a small molecule drug. The usage of the INN stem '-rafenib' in the name indicates that Uplarafenib is a Raf (rapidly accelerated fibrosarcoma) kinase inhibitor.
Diproteverine
go.drugbank.com/drugs/DB20318ExperimentalDiproteverine is a small molecule drug. The usage of the INN stem '-verine' in the name indicates that Diproteverine is a spasmolytic with a papaverine-like action.
Tefazoline
go.drugbank.com/drugs/DB20397ExperimentalTefazoline is a small molecule drug. The usage of the INN stem '-azoline' in the name indicates that Tefazoline is a antihistaminic or local vasoconstrictor, antazoline derivative.
Dalcotidine
go.drugbank.com/drugs/DB20406ExperimentalDalcotidine is a small molecule drug. The usage of the INN stem '-tidine' in the name indicates that Dalcotidine is a histamine- H2-receptor antagonist, cimetidine derivative.
Rovafovir etalafenamide
go.drugbank.com/drugs/DB14903InvestigationalRovafovir etalafenamide is under investigation in clinical trial NCT03472326 (Efficacy of GS-9131 Functional Monotherapy in HIV-1-Infected Adults Failing a Nucleos(t)Ide Reverse Transcriptase Inhibitor-Containing
Actoxumab
go.drugbank.com/drugs/DB16376InvestigationalActoxumab is under investigation in clinical trial NCT01241552 (A Study of MK-3415, MK-6072, and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-001)